N/A N=62 Effect of tDCS Timing on Safety Memory in PTSD
PTSD
Primary: Skin Conductance Responses — 0.075; 0.088; 0.057 Skin conductance in microsiemens — p=0.02
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=206 A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Type 2 Diabetes
Primary: Change From Baseline in Hemoglobin A1c (HbA1c) — -2.19; -1.75; -2.03; -0.77 percentage of HbA1c — p=<0.001
Phase 2 N=40 Open-Label of SPN-820 in Adults With Major Depressive Disorder
Major Depressive Disorder
Primary: Change From Baseline to Each Time Point in the Hamilton Depression Rating Scale-6 Items (HAM-D6) Total Score (HAM-D6). — -6.1; -7.2; -7.5; -7.8 score on a scale
Phase 2 N=25 A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Multiple Myeloma · Diarrhea
Primary: Number of Participants With Improvement of Lenalidomide-associated Diarrhea Evaluated by CTCAE 5.0 — 22; 3 Participants
Phase 2 N=65 Brentuximab Vedotin (SGN-35) in Transplant Eligible Patients With Relapsed or Refractory Hodgkin Lymphoma
Hodgkin's Lymphoma
Primary: FDG-PET/CT Standardized Uptake Value at 12 Months — 69; 27; 69; 30 Standardized Uptake Value (SUV)
Phase 3 N=967 Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Pancreatic Cancer · Pancreas Cancer · Pancreatic Diseases
Primary: Number of Participants Evaluated for the Effectiveness of Cefoxitin as a Surgical Antibiotic Prophylaxis. — 400; 378 Participants
N/A N=696 Pragmatic Obstructive Sleep Apnea Weight Loss Trial Assessing Effectiveness and Reach
Obesity · Sleep Apnea, Obstructive
Primary: Change in Sleep-related Quality of Life — 1.43; 0.93 units on a scale — p=0.001
Phase 2 N=50 Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Stage IIIC Fallopian Tube Cancer · Stage IIIC Ovarian Cancer · Stage IIIC Primary Peritoneal Cancer
Primary: Quality of Life (QOL) Assessed Using Functional Assessment of Cancer Therapy-Ovarian Questionnaire (FACT-O) — 116.32 score on a scale
N/A N=7,304 A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Thromboembolism
Primary: Mean All-Cause Healthcare Costs Per Participant Per Month (PPPM) for VTE Events — 16420; 21312 USD per participant per month — p=<0.0001
N/A N=31 Digital Incentive Spirometry Adherence
Pulmonary Function · Incentive Spirometry · Patient Adherence
Primary: Incentive Spirometry Adherence (Breath Attempts Per Day) — 45 Breath attempts
Phase 2 N=36 BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Hairy Cell Leukemia
Primary: Efficacy of Vemurafenib — 10; 14; 12 Participants
N/A N=10 Effects of an Overground Propulsion Neuroprosthesis in Community-dwelling Individuals After Stroke
Stroke
Primary: Immediate Change in Walking Speed — 0.01; 0.03 meters per second (m/s)
N/A N=119 Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses
Treatment
Primary: Progression-Free-Survival — 8.6; 11.3 month
Phase 2 N=37 Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia
Primary: Recommended Phase II Dose — 5 mg/m^2
Phase 2 N=27 Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
Recurrent Pericarditis
Primary: 11-point NRS Pain Score — -3.7 units on a scale